The firm posted a combined ratio of 80% for its P&C segment and 72.5% for its specialty unit, improving from 97.6%
PartnerRe improves Q4 non-life CR 21 points to 77.5% as specialty LR halves to 37.9%

The firm posted a combined ratio of 80% for its P&C segment and 72.5% for its specialty unit, improving from 97.6%